Correlation Between Cingulate Warrants and Syndax Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and Syndax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and Syndax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cingulate Warrants and Syndax Pharmaceuticals, you can compare the effects of market volatilities on Cingulate Warrants and Syndax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of Syndax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and Syndax Pharmaceuticals.

Diversification Opportunities for Cingulate Warrants and Syndax Pharmaceuticals

-0.54

Correlation Coefficient

Cingulate Warrants  Syndax Pharmaceuticals

Excellent diversification

The 3 months correlation between Cingulate and Syndax is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and Syndax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syndax Pharmaceuticals and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with Syndax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syndax Pharmaceuticals has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and Syndax Pharmaceuticals go up and down completely randomly.

Pair Corralation between Cingulate Warrants and Syndax Pharmaceuticals

Assuming the 90 days horizon Cingulate Warrants is expected to generate 6.29 times more return on investment than Syndax Pharmaceuticals. However, Cingulate Warrants is 6.29 times more volatile than Syndax Pharmaceuticals. It trades about 0.06 of its potential returns per unit of risk. Syndax Pharmaceuticals is currently generating about -0.02 per unit of risk. If you would invest  4.84  in Cingulate Warrants on December 2, 2024 and sell it today you would lose (1.51) from holding Cingulate Warrants or give up 31.2% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Cingulate Warrants  vs.  Syndax Pharmaceuticals

Cingulate Warrants

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Cingulate Warrants are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile technical and fundamental indicators, Cingulate Warrants showed solid returns over the last few months and may actually be approaching a breakup point.

Syndax Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Syndax Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental indicators, Syndax Pharmaceuticals is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Cingulate Warrants and Syndax Pharmaceuticals

The main advantage of trading using opposite Cingulate Warrants and Syndax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, Syndax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syndax Pharmaceuticals will offset losses from the drop in Syndax Pharmaceuticals' long position.

The idea behind Cingulate Warrants and Syndax Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.